Life-Science Panorama

A Journal for Industry Executives

Brought to you by

November 29th, 2011

It Depends On What The Meaning Of The Word ‘HIT’ Is

By Daniel R. Matlis and Ellyn McMullin

There is a famous quote: “It depends on what the meaning of the word ‘is’ is.”  The impact of Health Information Technology (HIT) on Patient Safety hinges on what the meaning of the word ‘HIT’ is. (Read: The Inside Scoop on FDA Healthcare IT Regulation )

On November 8, 2011 the Institute of Medicine (IOM) released a report entitled “Health IT and Patient Safety: Building Safer systems for Better Care.”  The Department of Health and Human Services (HHS) had asked the IOM to evaluate health IT safety concerns and to recommend ways that both the government and private sectors can make patient care safer using health IT.

“Just as the potential benefits of health IT are great, so are the possible harms to patient safety if these technologies are not being properly designed and used,” said Gail L. Warden, president emeritus of Henry Ford Health System and chair of the committee that wrote the report. “To protect patients, industry and government have a shared responsibility to ensure greater transparency, accountability, and reporting of health IT-related medical errors.”
One of the obstacles to improved patient safety that must be overcome is the contractual restrictions of sharing safety-related information between technology vendors and health care providers. Another is the realization that products are not used in isolation. Rather, they are part of a larger sociotechnical system includes, people (clinicians & patients), organizations, processes and the external environment. Safety emerges from the interactions of these factors.

One of the immediate concerns after reviewing the IOM report is that the definition of HIT and a medical device is unclear.  In the report IOM recommends that HHS implement a plan to address the following recommendations:

1. The Secretary of HHS should publish an action and surveillance plan within 12 months that includes a schedule for working with the private sector. The plan should specify
a. The Agency for Healthcare Research and Quality (AHRQ) and the National Library of Medicine (NLM) should expand their funding of research, training and education of safe practices related to the design, implementation, usability and safe use of health IT by all users.
b. The Office of the National Coordinator for Health IT (ONC) should expand its funding of processes that promote safety that should be followed in the development of health IT products.
c. ONC and AHRQ should work with health IT vendors and healthcare organizations to promote post deployment safety testing of Electronic Health Records (EHR) for high-prevalence, high impact EHR-related patient safety risks.
d. Health care accrediting organizations should adopt criteria relating to EHR safety.
e. AHRQ should fund the development of new methods for measuring the impact of health IT on safety using data from EHRs.
2. The Secretary of HHS should ensure insofar as possible that Health IT vendors support the free exchange of information about health IT experiences and issues and not prohibit sharing of such information relating to patient safety.
3. ONC should work with the private and public sectors to make comparative user experiences across vendors publicly available.
4. The Secretary of HHS should fund a new Health IT Safety Council to evaluate criteria for assessing and monitoring the safe use of health IT and the use of health IT to enhance safety. This council should operate within an existing voluntary consensus standards organization.
5. All health IT vendors should be required to publicly register and list their products with ONC,
6. The Secretary of HHS should specify the quality and risk management process requirements that health IT vendors must adopt, with a particular focus on human factors, safety culture, and usability.
7. The Secretary of HHS should establish a mechanism for both vendors and users to report health IT-related deaths, serious injuries, or unsafe conditions.
a. Reporting of health IT-related adverse events should be mandatory for vendors.
b. Reporting of health IT-related adverse events by users should be voluntary, confidential and nonpunitive.
c. Efforts to encourage reporting should be developed, such as removing the perceptual, cultural, contractual, legal and logistical barriers to reporting.
8. The Secretary of HHS should recommend that Congress establish an independent federal entity for investigating patient safety deaths, serious injuries, or potentially unsafe conditions associated with health IT. This entity should also monitor and analyze data and publicly report results of these activities.
9. A. The Secretary of HHS should monitor and publicly report on the progress of health IT safety annually beginning in 2012. If progress toward safety and reliability is not sufficient as determined by the Secretary, the Secretary should direct the FDA to exercise all available authorities to regulate EHRs, health information exchanges and personal health records (as opposed to the AHRQ & ONC as originally proposed).
B. The Secretary should immediately direct the FDA to begin developing the necessary framework for regulation. Such a framework should be in place if and when the Secretary decides that the state of IT safety requires FDA regulation as stipulated in Recommendation 9a above.

It is evident that the IOM puts a good deal of thought in responding to HHS’s request and came up with some reasoned recommendations. A key challenge for implementing IOM’s proposed plan is definitions. For example, should Electronic Medical Record systems (EMR) systems, be regulated as medical devices or are they General Purpose IT systems? (See http://lsp.axendia.com/MDDS)

Testimony by CDRH Director Shuren at the Health Information Technology (HIT) Policy Committee and provides FDA’s perspective on potential approaches to address HIT-related safety concerns. As part of this testimony Dr. Shuren used the following examples of adverse events for HIT under FDA’s Jurisdiction.

• An EMR system was connected to a patient monitoring system to chart vital signs. The system required a hospital staff member to download the vital signs, verify them, and electronically post them in the patient’s chart. Hospital staff reported that, several times, vital signs have been downloaded, viewed, and approved, and have subsequently disappeared from the system.

• Mean pressure values displayed on a patient’s physiological monitors did not match the mean pressures computed by the EMR system after systolic and diastolic values were entered.

• An improper database configuration caused manual patient allergy data entries to be overwritten during automatic updates of patient data from the hospital information system.

According to HIMMS Medical Device Meaningful Use Matrix:
“the Food and Drug Administration (FDA) has asserted that EHRs are Class 2 medical devices over which FDA has regulatory authority. The relationship between the FDA and the ONC is evolving and it is still unclear to what extent EHR systems will be regulated, yet it is important that the user devise a comprehensive program to evaluate and monitor HIT, in particular those HIT systems that integrate medical devices as part of the data collection process. It is important that one can measure the quality of care, not just the delivery.”

The impact of Health Information Technology (HIT) on Patient Safety depends on what the meaning of the word ‘HIT’ is.  Healthcare IT will play a progressively critical role in the delivery of Healthcare. ONC has encouraged the adoption of certified EHRs through its meaningful use criteria and authorized certification organization. As we become increasingly reliant on state of the art medical technology and HIT systems we must be mindful to mitigate the risks they may inject into the Healthcare ecosystem. The primary goal of HIT must be increased patient care safety and improved outcomes.

November 15th, 2011

Is That Car a Medical Device?

By Daniel R. Matlis

As wireless technology began converging with Health Care and consumer devices, the Wireless-Life Sciences Alliance (WLSA) was organized to bring together business leaders and researchers in Healthcare and Technology. WLSA’s mission is to improve access to affordable high quality healthcare, globally, by accelerating innovation in wireless connected medical devices, services and applications. WLSA focuses on identifying collaboration opportunities within the wireless health and consumer sectors. As a result, members of the association represent a very diverse group of companies including AT&T, Qualcomm, CareFusion, Johnson & Johnson, Procter & Gamble, Ascension Health, Sanofi, 3M and California Healthcare Foundation.

I recently had the opportunity to speak with Robert B. McCray, President & CEO of the WLSA, to discuss the impact the convergence of medical technology, connectivity and consumer devices is having on the delivery of healthcare. Mr. McCray has over 25 years of experience as a business owner, senior operating executive, legal and transactional advisor to private and public companies including the Healthcare industry.

A crucial area for the applicability of this convergence is the management of chronic diseases such as asthma and diabetes. “The first challenge here is how you capture the information needed to manage chronic disease in a way that’s really effective.” said Mr. McCray. “This quickly drives you toward a discussion of how to gather these data more passively, kind of ‘invisibly’ to the consumer.”

A great example of the use of convergence to support this challenge is Ford’s In-Car Health and Wellness Solutions. Researchers at Ford, in partnership with Medtronic and WellDoc, have developed a series of in-car health and wellness apps and services aimed at monitoring people with chronic illnesses or medical disorders so they can manage their condition while on the go. Ford leveraged SYNC® and its ability to connect devices via Bluetooth, access cloud-based Internet services and control smartphone apps, to develop voice-controlled in-car connections to an array of health aids from glucose monitoring devices to diabetes management services, asthma management tools and web-based allergen alert solutions.

“We had one of the cars on site at the Wireless Health 2011 Conference last month” Mr. McCray noted “We’re using the announcement that Ford made with Medtronic and WellDoc about their connected car with the diabetes and asthma applications as a focal point, since that’s the first time they’ve shown it in public.” At the conference, Ford’s senior technical leader, K. Venkatesh Prasad, discussed these innovations on a “Health and Wellness Connectivity Services on the Go” panel discussion with Anand Iyer, COO of WellDoc, and H. James Dallas, SVP at Medtronic.

The announcement begs the question: Is the Ford Car a medical device? “As much as the question is fun to ask, I am sure that Ford will not market the vehicle as a 3000-lb. medical device. It is an example of creative thinking applied to the problem of how to gather information when convenient for consumers,” said Mr. McCray. (see The Inside Scoop on FDA Healthcare IT Regulation )

According to Mr. McCray, the Healthcare industry needs to “take advantage of the consumer electronic technology to drive costs down through volume and by using existing tools, such as phones and global wireless systems, and really repurpose existing technology to meet healthcare goals.”

Mr. McCray also pointed out that “healthcare and medicine are moving very rapidly from analog to digital systems. In every other sector where this shift has happened, it has transformed the sector. It is my analysis that fundamentally, knowledge makes purchasers more powerful. This drives down the costs of knowledge and decreases its value to incumbents. For healthcare, I translate that into the value of diagnoses declining rapidly and freeing up more time to be spent on therapeutics and treatments, which is going to lead to really happier customers.”

I asked Mr. McCray: What does he see as barriers to the implementation or adoption of these technologies, whether they are Regulatory, cultural, usability, interoperability or others? What are the kinds of things that he sees hindering adoption?

According to Mr. McCray, “The key barriers are institutional. They are partially due to regulatory structures such as the control of professions over licensure and the state-by-state regulatory system that we have with respect to healthcare services. Professions don’t like competition. There are opportunities to rationalize how you deliver services and deliver diagnoses, but you can’t cross state lines if there are professions involved. And then, the FDA, too, is concerned about the potential that the technology will have on public health or the potential of bad publicity because someone home alone didn’t get the signal on her monitor. If they are worried about that and don’t let that kind of device go to market or make it really expensive, then we are just not going to realize the potential benefits. You can have the best technology and the life science know-how bundled up, but if you cannot figure out how to engage the consumer, it simply will not work and your market will not develop.”

There is certainly a revolution going on in healthcare, with the converging capabilities of technology and knowledge and the ability to get it out there. There are already wireless health applications and products in the market today that are saving lives. According to Mr. McCray, “They are not on a separate revenue line. The best example that I am aware of is what Medtronic, Boston, and St. Jude have done with their implanted defibrillators and their monitors.” A study involving patients with implanted cardiac defibrillators demonstrated that the five-year survival rate for patients followed up with only in office visits was 50 percent lower than for patients who were followed up on the network using a connected bedside monitor. (Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up; The ALTITUDE Survival Study. Leslie A. Saxon, MD; et al.
Circulation. 2010; 122: 2359-2367 Published online before print November 22, 2010, doi: 10.1161/CIRCULATIONAHA.110.960633).

We concluded the interview with Mr. McCray’s forecast on this trend.
“We have the opportunity to move the needle on the key issues of access to care, access to affordable care, and access to quality care on a global basis. It’s the biggest business opportunity in the world and the biggest need in the world. And that comes out of five billion cell phone subscribers or more, six or seven billion people on the planet in range of cell service, even if they don’t have their own phone. This is the biggest distribution channel that’s ever existed. With the digitization of content, to and from devices and people, we can take advantage of that distribution channel and use the knowledge that has been built up in the U.S. and other research centers in rich countries and apply it to billions of new people around the world. Price, where they can afford it, is going to make care and services more affordable in the rich countries that need it due to the economic conditions and budget challenges that we are all facing. So to me, it is the biggest thing in the world, and it is a problem that we can actually tackle. Clean water is something that billions of people in the world need, but there’s nothing you can do globally to tackle clean water. You just have to knock that out neighborhood by neighborhood. But with healthcare, powered digitization and wireless connectivity converging, we can actually move the needle and tackle markets of billions of people. That’s pretty exciting stuff. If I were thirty years old, I’d pick this sector again. More fun for the next thirty years than the last, probably.”

|